Two ways were used to block the interaction between FGF2 and FGFR2: one way used shRNA to knockdown FGF2 in MSCs, the other way was FGFR inhibitor BGJ398 to competitively combined with FGFR2 in leukaemia cells. This evidence concerns the gene FGFR2 and leukemia.